APL-400-047
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APL-400-047, covering 2008-09-29 to 2008-09-29. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers [Phase 1]